What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?

Journal Title: Central European Journal of Urology - Year 2014, Vol 67, Issue 1

Abstract

patients diagnosed with either idiopathic detrusor overactivity (IDO) or neurogenic detrusor overactivity (NDO). Material and methods Retrospective case–notes review of patients who were converted from 300IU to 200IU OnabotulinumtoxinA. Subjective patient reported improvements at interview and bladder diary reported parameters of urgency, urgency incontinence, frequency and nocturia. Results Forty–four patients had received 300IU OnabotulinumtoxinA and were switched to 200IU after July 2008, 28 for IDO and 16 for NDO. Thirty–seven patients reported ongoing improvement with 200IU OnabotulinumtoxinA, six patients had worsening in their symptoms since down–titrating to 200IU and one patient did not attend follow–up. Improvement in urgency and urgency incontinence episodes per day were 82% and 72%, respectively, in patients who received 200IU. Of the 44 patients, 39 continued to receive 200IU, four requested up–titration to 300IU (due to decreased effect) and one did not attend after the 1st treatment. After converting from 300IU to 200IU, additional three patients were started on CISC for de novo voiding difficulty. Conclusions Seventy–nine percent of patients were satisfied with their symptoms after switching from 300IU to 200IU OnabotulinumtoxinA. Only 9% of patients (all with NDO) reverted back to receiving 300IU. This study showed similar efficacy and longevity in the majority of patients (90%) using 200IU in both NDO and IDO.

Authors and Affiliations

Manar Malki, Altaf Mangera Mangera, Sheilagh Reid, Richard Inman, Christopher Chapple

Keywords

Related Articles

Infected urachal cyst in a young adult

The urachus is the remnant of the cloaca, which in adults attaches the bladder dome to the umbilicus. After birth it obliterates and presents as the midline umbilical ligament. Patent urachal anomalies are usually detect...

Secondary infertility and the aging male, overview

Introduction Old men preparing themselves for marriage late in their lives might face infertility. Infertility in this group of men should be considered from a wider perspective, as they face any age–related health troub...

Significance of ASAP and extensive HG-PIN in clinical practice

Introduction Prostate cancer (PCa) is one of the most commonly diagnosed neoplasms in elderly men. The precancerous lesion of PCa is considered a high-grade prostate intraepithelial neoplasm (HG-PIN), while atypical smal...

Testicular sarcoidosis masquerading as testicular carcinoma

We present a case of a 27–year–old man with a history of weight loss. A chest x–ray demonstrated hilar lymphadenopathy and he was treated with anti tuberculosis treatment. He noticed a painless left scrotal swelling and...

Download PDF file
  • EP ID EP333348
  • DOI -
  • Views 41
  • Downloads 0

How To Cite

Manar Malki, Altaf Mangera Mangera, Sheilagh Reid, Richard Inman, Christopher Chapple (2014). What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?. Central European Journal of Urology, 67(1), 35-40. https://europub.co.uk/articles/-A-333348